Market-based comparisons are difficult, but necessary
Tech startups are highly heterogeneous and approrpriate market data is scarce and complex. As a result, valuations based on comparable companies or deals often reflect sentiment rather than fundamentals.
But market-based comparisons are essential because they anchor valuation expectations, reflect real buying behaviour, strengthen positioning, and help startups negotiate on equal footing.
Valuing startups and growth-stage companies using market-based approaches
Done well, market-based analysis transforms a subjective valuation argument into a defensible, evidence-backed case�“something every tech-based venture needs when engaging investors or corporate partners.
By the end of this course, you will:
- Understand the fundamentals of enterprise and transaction valuation using market-based approaches.
- Be able to apply comparable company analysis and precedent transaction analysis to assess a startup’s worth.
- Gain the skills to adjust valuations for market conditions, strategic context, and company-specific factors.
- Learn to communicate enterprise value confidently to investors, partners, and potential acquirers.
Features and Benefits
Efficient Learning
Video tutorials and editable templates, featuring real-world examples, guide you through every detail.
Industry Expert Led
Developed and taught by investors, startup advisors, and founders.
Instant Access
Get started today. Enrol now for instant access.Course Details
This course equips founders and investors with practical tools and frameworks to determine a defensible enterprise valuation, enabling better strategic decision-making and successful negotiation in investment or exit scenarios. What You’ll Learn: Format: Self-paced online course Duration: ~1.5 - 2 hours Course Materials: Dr. Sophie Laurenson, PhD / Executive MBA CEO and Founder, MedDev Central With 20 years of experience in the medical device industry�“as a startup founder, corporate scientist, and investor, I’ve led and advised on valuations across the full product lifecycle, from early-stage concepts to due diligence and exit. My work spans financial modelling, IP strategy, corporate partnering and designing development and commercialisation plans specifically structured to maximise asset valuation. I’ve had the privilege of working with startups, corporates, and investors to navigate the complex dynamics of the MedTech landscape, aligning innovation with market needs and long-term value creation. I’m especially passionate about building pathways for medical devices that are not only clinically and commercially viable but also socially and environmentally sustainable. No legal or finance degree required�“just a desire to understand the real value of your business. Need a custom package? We offer tailored solutions for large teams, academic institutions, and accelerators. Contact us to discuss enterprise licensing or co-branded delivery. Financial support is available for female founders and those from select low and middle-income countries (LMICs).Course Curriculum
Format
Instructor
Who is it for?
Pricing
Course Price 199 Includes:
Ready to start?
Don’t leave your startup’s value to guesswork.
Sign up today and learn how to confidently determine valuations that attract investors and set your early-stage venture up for success.
Interested in learning more?
Watch our free Masterclass on enterprise and asset valuation:
Think your tech venture might need more advanced valuation methods?
Check out our other courses on business and asset valuation.
Enterprise Valuation: (for later-stage or revenue-generating businesses)
Intellectual Property Valuation:
Comparables / Market-based Valuation:
